Inferior vena cava agenesis with exuberant collateral circulation

Abstract is not required for Clinical Images (This page in not part of the published article.) International Journal of Case Reports and Images, Vol. 8 No. 1, January 2017. ISSN – [0976-3198] Int J Case Rep Images 2017;8(1):86–88. www.ijcasereportsandimages.com Cristino et al. 86 CASE REPORT OPEN ACCESS Inferior vena cava agenesis with exuberant collateral circulation Ana Vaz Cristino, Renata Silva, Carmen Pais, José Presa


CASE REPORT
We present a case of 55-year-old female with a history of past alcohol consumption (75 g/day for ten years), with no other relevant medical history, who was referred to our hepatology unit. She presented with leukopenia and thrombocytopenia, normal mean corpuscular volume, mildly elevated total bilirubin (1.8 mg/dL), alkaline phosphatase (192 U/L) and gamma-glutamyl transferase (127 U/L), with normal aminotransferases, albumin and coagulation. Physical examination revealed exuberant collateral circulation of the abdominal wall ( Figure 1). The esophagoduodenoscopy revealed grade III esophageal varices, and the abdominal ultrasonography showed hypertrophy of the caudate lobe and heterogeneous echotexture, and splenomegaly with collateral circulation of the splenic hilum. The autoimmune study, hepatitis serologies and iron studies were normal, and the transient elastography was 48 Kpa, consistent with liver cirrhosis. A computed tomography (CT) scan of the abdomen ( Figure 2A) revealed exuberant retrocrural collateral circulation, with varices in the azygos and hemiazygos systems, hepatorenal and splenorenal spaces, with lack of permeability in the inferior vena cava, between the renal and the suprahepatic veins. The magnetic resonance angiography ( Figure 2B) confirmed inferior vena cava agenesis.
Due to beta-blocker intolerance, the esophageal varices were obliterated with endoscopic variceal ligation. She remains in follow-up after three years.

DISCUSSION
In this case, a history of alcohol consumption had been assumed as cause for liver cirrhosis and evidence of portal hypertension. The exuberance of collateral circulation prompted further image studies, with the diagnosis of inferior vena cava agenesis [1,2].
Although considered a rare condition, the number of diagnosed cases is increasing, and it is thought that this condition may be underdiagnosed, mainly because most patients are asymptomatic [3].
The best methods for imagiological evaluation are computed tomography scan and magnetic resonance angiography [4].
These individuals generally develop extensive collateral circulation, and it is associated with diverse manifestations, such as deep venous thrombosis [2], lumbosacral radiculopathy and myelopathy due to venous congestion [5], congenital heart disease, splenic abnormalities and liver disease due to inadequate portal flow, with portal hypertension, development of nodal nodular hyperplasia and hepatic tumors. Portal hypertension and hepatic encephalopathy are uncommon before adulthood [4].
The management of inferior vena cava agenesis depends on the anatomical alterations and clinical manifestations of the disease, in a case-by-case basis [4]. High thrombotic risk and presence of liver tumors are important factors to have in mind in patients with this condition.

CONCLUSION
Inferior vena cava agenesis is a rare condition, but recent evidence shows that it may be underdiagnosed, and can be simply detected with current image methods. Diagnosing inferior vena cava has potential implications on patient management, but it can be challenging due to lack of symptoms.

Edorium Journals: An introduction
Edorium Journals Team

But why should you publish with Edorium Journals?
In less than 10 words -we give you what no one does.

Vision of being the best
We have the vision of making our journals the best and the most authoritative journals in their respective specialties. We are working towards this goal every day of every week of every month of every year.

Exceptional services
We care for you, your work and your time. Our efficient, personalized and courteous services are a testimony to this.

Editorial Review
All manuscripts submitted to Edorium Journals undergo pre-processing review, first editorial review, peer review, second editorial review and finally third editorial review.

Peer Review
All manuscripts submitted to Edorium Journals undergo anonymous, double-blind, external peer review.

Early View version
Early View version of your manuscript will be published in the journal within 72 hours of final acceptance.

Manuscript status
From submission to publication of your article you will get regular updates (minimum six times) about status of your manuscripts directly in your email.

Favored Author program
One email is all it takes to become our favored author. You will not only get fee waivers but also get information and insights about scholarly publishing.

Institutional Membership program
Join our Institutional Memberships program and help scholars from your institute make their research accessible to all and save thousands of dollars in fees make their research accessible to all.

Our presence
We have some of the best designed publication formats. Our websites are very user friendly and enable you to do your work very easily with no hassle. Something more...
We request you to have a look at our website to know more about us and our services.
We welcome you to interact with us, share with us, join us and of course publish with us.

Invitation for article submission
We sincerely invite you to submit your valuable research for publication to Edorium Journals.

Six weeks
You will get first decision on your manuscript within six weeks (42 days) of submission. If we fail to honor this by even one day, we will publish your manuscript free of charge.*

Four weeks
After we receive page proofs, your manuscript will be published in the journal within four weeks (31 days). If we fail to honor this by even one day, we will publish your manuscript free of charge and refund you the full article publication charges you paid for your manuscript.* This page is not a part of the published article. This page is an introduction to Edorium Journals and the publication services. * Terms and condition apply. Please see Edorium Journals website for more information.